Pulmonary hypertension and nailfold capillaroscopic pattern in systemic sclerosis patients treated with Iloprost and Bosentan: Preliminary report

被引：0
|
作者：
Bellissimo, S
Di Girolamo, C
Ferrucci, MG
Gallo, A
Venditti, C
Stisi, S
机构：
[1] Gaetano Rummo Hosp, Rheumatol Unit, Benevento, Italy
[2] Gaetano Rummo Hosp, Rheumatol Unit, Benevento, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：285 / 285
页数：1
相关论文
共 50 条
  • [21] SYSTEMIC SCLEROSIS PATIENTS WITH AND WITHOUT PULMONARY ARTERIAL HYPERTENSION: A NAILFOLD CAPILLAROSCOPY SURVEY
    Riccieri, V.
    Vasilc, M.
    Macri, V.
    Sciarra, I.
    Stefanantoni, K.
    Vizza, C. D.
    Badagliacca, R.
    Poscia, R.
    Crescenzi, E.
    Valesini, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S130 - S131
  • [22] Effect of bosentan in pulmonary hypertension development in systemic sclerosis patients with digital ulcers
    Castellvi, Ivan
    Simeon, Carmen Pilar
    Sarmiento, Monica
    Casademont, Jordi
    Corominas, Hector
    Fonollosa, Vicenc
    PLOS ONE, 2020, 15 (12):
  • [23] Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
    Hoeper, M. M.
    Leuchte, H.
    Halank, M.
    Wilkens, H.
    Meyer, F. J.
    Seyfarth, H. J.
    Wensel, R.
    Ripken, F.
    Bremer, H.
    Kluge, S.
    Hoeffken, G.
    Behr, J.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (04) : 691 - 694
  • [24] SPECIFIC ALTERATIONS OF NAILFOLD CAPILLARIES MIGHT ANTICIPATE THE APPEARANCE OF THE EARLY CAPILLAROSCOPIC SCLERODERMA-PATTERN IN SYSTEMIC SCLEROSIS PATIENTS
    Pendolino, Monica
    Pizzorni, Carmen
    Sulli, Alberto
    Paolino, Sabrina
    Tomatis, Veronica
    Alessandri, Elisa
    Goegan, Federica
    Smith, Vanessa
    Cutolo, Maurizio
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1223 - 1224
  • [25] Experience with bosentan in pulmonary arterial hypertension secondary to systemic sclerosis
    Caroline Barranco
    Nature Clinical Practice Rheumatology, 2006, 2 (4): : 181 - 181
  • [26] Bosentan treatment in pulmonary arterial hypertension secondary to systemic sclerosis
    Piludu, G.
    Nalli, E.
    Amoresano, D.
    Farci, M.
    Muttini, T.
    D'Aietti, I
    Mura, N.
    Loddo, M.
    Giacco, G.
    ALLERGY, 2008, 63 : 353 - 353
  • [27] Progression of Microvascular Damage Through Different Nailfold Capillaroscopic Patterns in Systemic Sclerosis Patients
    Sulli, Alberto
    Ravera, Francesca
    Ruaro, Barbara
    Smith, Vanessa
    Pizzorni, Carmen
    Zampogna, Giuseppe
    Alessandri, Elisa
    Cutolo, Maurizio
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S576 - S576
  • [28] Impact of bosentan therapy on stress-induced pulmonary hypertension in patients with systemic sclerosis
    Volkov, A. V.
    Kurmukov, I. A
    Yudkina, N. N.
    Glukhova, S. I.
    Nikolaeva, E. V.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (01): : 49 - 56
  • [29] Looking for a "Very Early" Nailfold Capillaroscopic Pattern: Specific Alterations of Nailfold Capillaries May Precede the Validated Scleroderma-Patterns in Systemic Sclerosis Patients
    Pendolino, Monica
    Pizzorni, Carmen
    Paolino, Sabrina
    Tomatis, Veronica
    Alessandri, Elisa
    Sulli, Alberto
    Goegan, Federica
    Smith, Vanessa
    Cutolo, Maurizio
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [30] Bosentan Improves Skin Perfusion of Hands in Patients with Systemic Sclerosis with Pulmonary Arterial Hypertension
    Rosato, Edoardo
    Molinaro, Ilenia
    Borghese, Federica
    Rossi, Carmelina
    Pisarri, Simonetta
    Salsano, Felice
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (12) : 2531 - 2539
12345